Rational Design of a JAK1-Selective siRNA Inhibitor for the Modulation of Autoimmunity in the Skin

The fully chemically modified siRNA supported efficient silencing of JAK1 expression in human skin explant and modulation of JAK1-dependent inflammatory signaling. A single injection into mouse skin enabled five weeks of duration of effect.